SCHEMBL8633406

SCHEMBL8633406

CC(C)CNC(=O)[C@H](C)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.56
CYP2C19 P33261 1/20 0.56
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
MMP1 P03956 1/20 0.48
MMP8 P22894 1/20 0.48
HPGD P15428 2/20 0.43
EPHX1 P07099 2/20 0.41
MAPT P10636 2/20 0.41
HSD17B10 Q99714 2/20 0.41
GAA P10253 1/20 0.41
TAS1R3 Q7RTX0 1/20 0.39
TAS1R1 Q7RTX1 1/20 0.39
TAS1R2 Q8TE23 1/20 0.39
LMNA P02545 1/20 0.39
ALDH1A1 P00352 1/20 0.38
ANPEP P15144 1/20 0.38
DNPEP Q9ULA0 1/20 0.38
TP53 P04637 2/20 0.37
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23866601 1.00 CYP2D6 (0.56) CYP2D6CYP2C19KMT2AMEN1MMP1
SCHEMBL2315958 1.00 CYP2D6 (0.56) CYP2D6CYP2C19KMT2AMEN1MMP1
SCHEMBL8195763 0.84 MEN1 (0.50) CYP2D6CYP2C19KMT2AMEN1MMP1
SCHEMBL1582718 0.84 MEN1 (0.50) CYP2D6CYP2C19KMT2AMEN1MMP1
SCHEMBL3354440 0.81 CYP2D6 (0.59) CYP2D6CYP2C19KMT2AMEN1MMP1
SCHEMBL1583004 0.80 MEN1 (0.47) CYP2D6CYP2C19KMT2AMEN1MMP1
SCHEMBL15374903 0.78 MEN1 (0.45) CYP2D6CYP2C19KMT2AMEN1HPGD
SCHEMBL18212154 0.78 MEN1 (0.45) CYP2D6CYP2C19KMT2AMEN1GAA
SCHEMBL15374899 0.78 MEN1 (0.45) CYP2D6CYP2C19KMT2AMEN1HPGD
SCHEMBL18212166 0.78 MEN1 (0.45) CYP2D6CYP2C19KMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0821675-A1 NOVEL HYDROXAMIC ACID AND AMINO-CARBOXYLATE COMPOUNDS AS METALLOPROTEASE AND TNF INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-02-04 EP disclosed
WO-1996033176-A1 NOVEL HYDROXAMIC ACID AND AMINO-CARBOXYLATE COMPOUNDS AS METALLOPROTEASE AND TNF INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-10-24 WO disclosed